Instituto de Diagnóstico S.A. (SNSE:INDISA)
Chile
· Delayed Price · Currency is CLP 2,530.90
+2.50 (0.10%)
At close: Mar 6, 2026
Instituto de Diagnóstico Revenue
Instituto de Diagnóstico had revenue of 70.43B CLP in the quarter ending September 30, 2025, with 16.22% growth. This brings the company's revenue in the last twelve months to 262.52B, up 11.56% year-over-year. In the year 2024, Instituto de Diagnóstico had annual revenue of 239.07B with 9.20% growth.
Revenue (ttm)
262.52B
Revenue Growth
+11.56%
P/S Ratio
1.48
Revenue / Employee
88.10M
Employees
2,980
Market Cap
387.44B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 239.07B | 20.14B | 9.20% |
| Dec 31, 2023 | 218.93B | 27.65B | 14.45% |
| Dec 31, 2022 | 191.29B | 2.75B | 1.46% |
| Dec 31, 2021 | 188.54B | 49.19B | 35.30% |
| Dec 31, 2020 | 139.36B | -10.83B | -7.21% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Administradora Americana de Inversiones | 202.15B |
| Salmones Camanchaca | 347.43B |
| Holding Bursátil Regional | 149.66B |
| Camanchaca | 829.75B |
| Cementos Bio Bio | 367.24B |
| Telefónica Chile | 881.59B |
| Oxiquim | 245.07B |
| Almendral | 2,876.42B |